Quintiles Transnational Corp. has signed an agreement to acquire Eidetics, a privately held consulting firm located in Boston. Eidetics provides research-based market insights and data analytics to support business decision making in drug development and commercialization. No purchase price was disclosed.
   
The acquisition of expands Quintiles' consulting offerings in the areas of product development, commercialization and market access. Quintiles is expanding its consulting practices in an effort to help its pharmaceutical, biotech and medical device clients navigate the complex business environment.
   
"The addition of Eidetics to our Quintiles Consulting business will further strengthen our ability to provide our clients with distinctive, data-driven, strategic solutions to their toughest challenges throughout the product lifecycle," said Jay Norman, president, Quintiles Consulting.
   
"We are excited about the opportunity to become part of the Quintiles organization," said Jim Kirk, partner at Eidetics. "We believe that joining Quintiles Consulting will build upon the past success of Eidetics' business, while providing our clients enhanced clinical, patient and provider data, greater therapeutic depth and access to global resources."